🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 372446104
- Market Cap
- Small Cap
- IPO
- $5.00/share
Business: Genprex, Inc. is a clinical stage gene therapy company developing a new approach to treating cancer. Genprex’s platform technologies are designed to administer cancer fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities.
Company Contact
- CEO
- Ryan M. Confer
- CFO
- Ryan M. Confer
- Headquarters
- 3300 Bee Cave Road, #650-227, Austin, TX 78746
- Phone
- 512-537-7997
- Investor Relations
- 877-774-4679 · investors@genprex.com